search
Back to results

The SIMPLY-B Study

Primary Purpose

Hepatitis B Virus Related Hepatocellular Carcinoma

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
The Simply B Study
Sponsored by
Nadine Barnes
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Hepatitis B Virus Related Hepatocellular Carcinoma

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Aged ≥18 years Attended participating primary care clinic in the preceding 36 months (June 1, 2019-June 30, 2022) or attended the clinic during the study period HBsAg positive Treatment naïve Not receiving specialist hepatitis B care Exclusion Criteria: < 18 years of age Already on hepatitis B treatment Already attending hepatitis B specialist care Hepatitis C or hepatitis D coinfection HIV coinfection Pregnant

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Patients living with hepatitis B

    Arm Description

    Patients living with hepatitis B will be managed at the GP clinic using the Simply B e-support package

    Outcomes

    Primary Outcome Measures

    Number of patients previously diagnosed with chronic hepatitis B within each primary care clinic study site who have attended the clinic within the 36-month period prior to implementation of the intervention
    Number of patients previously diagnosed with chronic hepatitis B within each primary care clinic study site who have attended the clinic within the 36-month period prior to implementation of the intervention
    Number (proportion) of hepatitis B patients receiving guideline-based hepatitis B management by GP
    Number (proportion) of hepatitis B patients receiving guideline-based hepatitis B management by GP
    Number (proportion) of hepatitis B patients receiving specialist care in a hospital or private setting
    Number (proportion) of hepatitis B patients receiving specialist care in a hospital or private setting
    Number (proportion) of hepatitis B patients receiving treatment by the GP in primary care
    Number (proportion) of hepatitis B patients receiving treatment by the GP in primary care

    Secondary Outcome Measures

    Acceptability and feasibility of using the Simply B package to facilitate hepatitis B management by GPs in primary care from health worker and patient perspectives.
    Acceptability and feasibility of using the Simply B package to facilitate hepatitis B management by GPs in primary care from health worker and patient perspectives. This will be done via a 12-month post implementation semi-structured interview with GPs, nurses, practices managers and patients living with hepatitis B.

    Full Information

    First Posted
    October 25, 2022
    Last Updated
    November 7, 2022
    Sponsor
    Nadine Barnes
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05614466
    Brief Title
    The SIMPLY-B Study
    Official Title
    SIMPLY-B Study - A Pilot Evaluation of a Primary Care E-support Package of Automated Case Finding, Simplified Treatment Algorithm and Decision Support to Increase Hepatitis B Treatment Uptake in Primary Care Clinics
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    April 2023 (Anticipated)
    Primary Completion Date
    June 2025 (Anticipated)
    Study Completion Date
    October 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Nadine Barnes

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    This study will be conducted in three parts: Part A: A prospective open label pilot intervention study, comparing the proportion of people with hepatitis B who are managed by their GP in primary care settings before, 12 months and 24 months after implementation of the Simply B electronic hepatitis B support package. Part B: A nested qualitative health services feasibility study using semi -structured interviews and thematic analysis
    Detailed Description
    The Simply B electronic GP support package consists of: Semi-automated hepatitis B case-finding in the primary care clinic using clinic EMR software Automated blood test ordering using clinic EMR software A simplified hepatitis B treatment algorithm and online e-support tool that provides the GP with a simplified management plan based on clinical data entered into the tool by generating a hepatitis B chronic disease management plan. Automated rapid linkage to specialist support through the e-support tool, with a follow up call from a specialist nurse provided within two business days of the initial patient/GP consultation. Clinical data collection through the e-support tool into an online secure database, visible by the GP and hospital specialist, allowing automated reminders and monitoring of timely and appropriate hepatitis B management steps. Linkage of de-identified data drawn from the Simply B database to the ACCESS and PATRON surveillance network to allow monitoring of progress toward National Strategy Hepatitis B treatment targets in primary care. The e-support tool is based on an online RedCAP database accessible to both the GP and St Vincent's hospital specialist team via different interfaces and stored securely on the St Vincent's Hospital Cloud. The investigators have partnered with the Future Health Today (FHT) software development team (University of Melbourne) to integrate the Simply B e-support package into primary care electronic medical record software. The GP enters demographic and pathology result data into a simple online data entry form. Based on a simplified hepatitis B management algorithm, this determines treatment eligibility and immediately generates an automatic patient management plan. For clinics that are part of the FHT network, FHT extracts demographic and pathology result data automatically and populates the Simply B tool, therefore the GP does not need to manually enter any data. Instructions of how to treat, monitor and perform liver cancer surveillance are included in the automated management plan. The hospital specialist nurse and specialist clinicians have online access to the 'back end' of the Simply B e-support tool database, allowing them to monitor and enter data. This database contains all the demographic and clinical data entered by the GP in the e-support tool data entry form and automatically generates dates for follow up review, including date of next liver cancer surveillance if the patient fulfils eligibility criteria. Upcoming milestone appointments trigger alert emails to the GP and specialist hepatitis nurses facilitating timely hepatitis B management.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hepatitis B Virus Related Hepatocellular Carcinoma

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    100 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Patients living with hepatitis B
    Arm Type
    Experimental
    Arm Description
    Patients living with hepatitis B will be managed at the GP clinic using the Simply B e-support package
    Intervention Type
    Other
    Intervention Name(s)
    The Simply B Study
    Intervention Description
    This study will be conducted in three parts: Part A: A prospective open label pilot intervention study, comparing the proportion of people with hepatitis B who are managed by their GP in primary care clinics before, 12 months and 24 months after implementation of the Simply B electronic hepatitis B support package. Part B: A nested qualitative health services feasibility study using semi -structured interviews and thematic analysis Part C: A mathematical modelling study using a Markov model to determine cost effectiveness of Simply B for increasing hepatitis B treatment uptake compared to status quo of hospital care.
    Primary Outcome Measure Information:
    Title
    Number of patients previously diagnosed with chronic hepatitis B within each primary care clinic study site who have attended the clinic within the 36-month period prior to implementation of the intervention
    Description
    Number of patients previously diagnosed with chronic hepatitis B within each primary care clinic study site who have attended the clinic within the 36-month period prior to implementation of the intervention
    Time Frame
    36 months prior to study
    Title
    Number (proportion) of hepatitis B patients receiving guideline-based hepatitis B management by GP
    Description
    Number (proportion) of hepatitis B patients receiving guideline-based hepatitis B management by GP
    Time Frame
    2 years
    Title
    Number (proportion) of hepatitis B patients receiving specialist care in a hospital or private setting
    Description
    Number (proportion) of hepatitis B patients receiving specialist care in a hospital or private setting
    Time Frame
    2 years
    Title
    Number (proportion) of hepatitis B patients receiving treatment by the GP in primary care
    Description
    Number (proportion) of hepatitis B patients receiving treatment by the GP in primary care
    Time Frame
    2 years
    Secondary Outcome Measure Information:
    Title
    Acceptability and feasibility of using the Simply B package to facilitate hepatitis B management by GPs in primary care from health worker and patient perspectives.
    Description
    Acceptability and feasibility of using the Simply B package to facilitate hepatitis B management by GPs in primary care from health worker and patient perspectives. This will be done via a 12-month post implementation semi-structured interview with GPs, nurses, practices managers and patients living with hepatitis B.
    Time Frame
    2 years

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Aged ≥18 years Attended participating primary care clinic in the preceding 36 months (June 1, 2019-June 30, 2022) or attended the clinic during the study period HBsAg positive Treatment naïve Not receiving specialist hepatitis B care Exclusion Criteria: < 18 years of age Already on hepatitis B treatment Already attending hepatitis B specialist care Hepatitis C or hepatitis D coinfection HIV coinfection Pregnant

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    The SIMPLY-B Study

    We'll reach out to this number within 24 hrs